Date Initiated by Firm | February 14, 2024 |
Date Posted | March 22, 2024 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-1369-2024 |
Recall Event ID |
94088 |
Product Classification |
Test, cystatin c - Product Code NDY
|
Product | Cystatin C Calibrator - In vitro diagnostic (IVD) use in the calibration of the Randox Cystatin C assay on automated analysers
Catalog Number: CVS 2699 |
Code Information |
GTIN: 05055273207439
(1) Batch 600957 Lot 1378CY - 1382CY
(2) Batch 621809, 621815 Lot 1403CY - 1407CY
(3) Batch 650533 Lot 1414CY - 1418CY |
Recalling Firm/ Manufacturer |
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
|
Manufacturer Reason for Recall | Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods |
FDA Determined Cause 2 | Under Investigation by firm |
Action | Randox Laboratories Ltd, UK ( manufacturer) notified the US Distributor Randox Laboratories USA . The distributor initial contact and the follow up contact via email on 2/20/24. Letter states reason for recall, health risk and action to take:
We have realigned the target values in the
above lot numbers to the IFCC Reference Standard. Please refer to the table below for the
updated calibrator targets. You may experience a positive shift in Quality Control and patient
sample recovery. If you are using CVS 2699 batch 600957 lots 1378CY-1382CY please provide
proof of scrappage and a replacement calibrator lot will be provided. Please discard all copies of the calibrator Instructions For Use (IFU)s and download the updated IFUs from
www.randox.com. If further information is required, please contact technical.services@randox.com .
In line with the realignment to the Cystatin C Calibrator Series, we are updating the target
and range for the Cystatin C controls, CYS5019 and CYS5020. The updated target and range can be found in the table below. Please discard any copies of the IFU and download the updated version from www.randox.com.
|
Quantity in Commerce | 666 units |
Distribution | US Nationwide distribution in the states of CA, IN. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|